New Initiative on Illicit Fentanyl's Danger
The Partnership for Safe Medicine 2018 Interchange held in Washington D.C. on June 7th brought together policymakers, counterfeit drug victims, pharmaceutical manufacturers, patient advocates, law enforcement, and healthcare professionals to discuss solutions to the deadly impacts that counterfeit drugs are having upon U.S. Citizens.
Venture Global's Managing Partner, Sven Bergmann, conducted a panel discussion on Introducing the Fentanyl Council. This is PSM's joint project to raise awareness of illicit fentanyl's danger and develop state and federal solutions.
See full presentation on Slideshare here.
Watch a recap of the discussion below. Bergmann's panel begins at 3 hours and 10 minutes.
Feel free to begin a discussion, offer a comment, or request more information about consultancy by emailing Sven Bergmann at [email protected].
Bergmann is a Managing Partner at Venture Global and advises brand owners, technology providers and governments on anti-counterfeit strategies, programmes and technologies.
